Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|7|1|24-29

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.7, Iss.1, 2008-03, pp. : 24-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase-Catalyzed Post-Translational Modifications of Proteins in the Nervous System and their Possible Involvement in Neurodegenerative Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 4, 2008-10 ,pp. : 370-375

Bentham Science Publishers

Access to resources Recommend Favorite

Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic

By  

Current Medicinal Chemistry, Vol. 13, Iss. 16, 2006-07 ,pp. : 1895-1902

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic #946; Cell Function: Potential Therapeutic Implications

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 129-139

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation of Foxo-Dependent Transcription by Post-Translational Modifications

By  

Current Drug Targets, Vol. 12, Iss. 9, 2011-08 ,pp. : 1303-1310

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite